Postal Ballot Notice for Appointment of Mr. Tarun Garg as MD and CEO

Management Changes View source PDF Explain this filing

HYUNDAI · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.3%Reaction day

₹2350.00

prior close

₹2351.80

announcement price

In-mkt

timing

Nifty 100market · index membership as recorded later (tracked since Jun 2026)+0.4%-0.1% vs market

Passenger Cars & Utility Vehicles peers, median of 6sector-0.5%+0.8% vs sector

On the reaction day the stock moved 0.1 pts less than Nifty 100 and 0.8 pts more than its Passenger Cars & Utility Vehicles peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

+0.2

15m

+0.1

30m

+0.3

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.3+0.4-0.1-0.5+0.8

Next day

+1.9+1.0+0.9-0.8+2.8

+2.6+1.0+1.5-1.6+4.1

+0.3+1.1-0.9-1.2+1.4

+1.0+1.6-0.6-2.0+3.0

+1.9+1.1+0.8-2.7+4.5

-0.7+2.0-2.7-3.0+2.3

15d

+1.2+1.4-0.2-2.4+3.6

-0.3+0.7-1.0-7.0+6.7

-2.5+0.5-3.0-0.2-2.3

-6.9+1.4-8.3-3.8-3.2

UpDownMarket · Nifty 100Sector · Passenger Cars & Utility Vehicles peers, median of 6Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Hyundai Motor India has sent a Postal Ballot Notice seeking shareholder approval to appoint Mr. Tarun Garg as Managing Director and CEO from January 1, 2026 to August 31, 2028. He has been on the Board since August 2020 and led the company's USD 19 billion IPO. Monthly remuneration up to about Rs 1.62 crore plus perks and performance incentives. E-voting runs November 12 to December 11, 2025; results by December 15, 2025.

Likely market impact

Internal leadership elevation to MD and CEO. Postal ballot outcome expected by December 15, 2025; near-certain approval given promoter control.